Author： Bedke Jens Stenzl Arnulf
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.10, 2013-10, pp. : 1329-1336
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Everolimus: In Advanced Renal Cell Carcinoma
By Garnock-Jones Karly P. Keating Gillian M.
Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. :
Emerging drugs for renal cell carcinoma
By Varella Leticia Rini Brian I
Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. :
Adjuvant treatment for renal cell carcinoma
By Lam John S Belldegrun Arie S Figlin Robert A
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. :
Emerging drugs for renal cell carcinoma
By Shaheen Philip E Bukowski Ronald M
Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. :